Works matching IS 10781552 AND DT 2024 AND VI 30 AND IP 1


Results: 33
    1
    2
    3
    4
    5
    6
    7
    8

    Cabozantinib-induced heart failure.

    Published in:
    Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 1, p. 225, doi. 10.1177/10781552231203703
    By:
    • Sekmek, Serhat;
    • Bayram, Dogan;
    • Ucar, Gokhan;
    • Civelek, Burak;
    • Kos, Fahriye Tugba;
    • Uncu, Dogan
    Publication type:
    Article
    9
    10
    11

    Niraparib-induced pure red cell aplasia.

    Published in:
    Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 1, p. 210, doi. 10.1177/10781552231197808
    By:
    • Bir Yücel, Kadriye;
    • Yıldız, Seyma;
    • Sütcüoglu, Osman;
    • Güvercin, Fatma Sena;
    • Uyar Göçün, Pınar;
    • Özdemir, Nuriye;
    • Yazıcı, Ozan;
    • Özet, Ahmet
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    GEDEFO-SEFH management of antineoplastic extravasations survey results.

    Published in:
    Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 1, p. 67, doi. 10.1177/10781552231167873
    By:
    • Jiménez-Pulido, Inmaculada;
    • Albert-Marí, María Asunción;
    • Conde-Estévez, David;
    • San José-Ruiz, Begoña;
    • Gil-Lemus, María Ángeles;
    • Cercós-LLetí, Ana Cristina;
    • Esteban-Mensua, María Jesús;
    • Díaz-Carrasco, María Sacramento
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33